HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hermogenes N Jimenez Selected Research

Levodopa (L Dopa)

3/2013Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hermogenes N Jimenez Research Topics

Disease

1Dyskinesias (Dyskinesia)
03/2013
1Catalepsy
03/2013
1Parkinson Disease (Parkinson's Disease)
03/2013
1Mental Disorders (Mental Disorder)
11/2012

Drug/Important Bio-Agent (IBA)

1N1- (3,4- dichlorophenyl)- cyclohexane- 1,2- dicarboxamideIBA
03/2013
1Glutamic Acid (Glutamate)FDA Link
03/2013
1metabotropic glutamate receptor 4IBA
03/2013
1Dopamine (Intropin)FDA LinkGeneric
03/2013
1Haloperidol (Haldol)FDA LinkGeneric
03/2013
1Levodopa (L Dopa)FDA LinkGeneric
03/2013
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2012